[Pathogenetic therapy in pulmonary tuberculosis].
Clinico-biochemical comparisons with an account of the peculiar characteristics of the tuberculosis process showed that it was advisable to use antioxidants as antifibrotic pathogenetic agents. The most pronounced effect was observed when combinations of two antioxidants or one antioxidant with lidase were applied.
Starostenko
E V
EV
D000975:Antioxidants / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000627:therapeutic use*; D006801:Humans; D015227:Lipid Peroxidation; D011239:Prednisolone / Q000627:therapeutic use; D013885:Thiosulfates / Q000627:therapeutic use; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D014810:Vitamin E / Q000627:therapeutic use
D000975:Antioxidants; D000995:Antitubercular Agents; D005938:Glucocorticoids; D013885:Thiosulfates; D014810:Vitamin E; D011239:Prednisolone; C017717:sodium thiosulfate
Patogeneticheskaia terapiia pri tuberkuleze legkikh.